The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)
The rapid increase in antimicrobial resistance (AMR) indicates the end of the “golden age” of antibiotics and threatens to undermine the major advances of modern medicine. In 2023, approximately one in six [...] Read More
Granulomatous mastitis (GM) is a rare inflammatory disease of the breast. Lactation disorders resulting in milk stasis, hyperprolactinemia, and blunt trauma to the breast are recognized predisposing factors for GM. Radiological imaging, core [...] Read More
Multidrug-resistant organisms (MDROs) are common causes of healthcare-associated infections (HAIs), which result in adverse patient outcomes, substantial morbidity and mortality, and increased healthcare-related costs. A growing body of literature [...] Read More
Surgical site infections (SSIs) remain one of the most common and serious hospital-acquired infections (HAIs), despite continuous technological advancements in modern medicine. Depending on the type of surgery, the incidence [...] Read More
Tuberculosis (TB) remains a major global infectious disease and an important cause of preventable mortality. According to the World Health Organization (WHO) Global Tuberculosis Report 2025, an estimated 10.7 million people [...] Read More
Acute bacterial meningitis (ABM) is a rapidly progressive disease with outbreak potential and remains associated with substantial morbidity and mortality worldwide. Although vaccination programs have significantly reduced the incidence of several major pathogens, ABM [...] Read More
Hydatid disease is a parasitic infection caused by Echinococcus granulosus and Echinococcus multilocularis. The life cycle of E. granulosus involves two main hosts: an intermediate host and a definitive host. Dogs are the most common [...] Read More
Earthquakes are natural disasters that impact thousands of individuals. The mass destruction caused by earthquakes leads to a surge in admissions to healthcare facilities. In addition to direct structural damage, earthquake-related secondary [...] Read More
Immune checkpoint inhibitor (ICI) therapy is a groundbreaking advancement in the field of oncology, with widespread use in the treatment of multiple solid-organ malignancies, including lung cancer, providing significant survival benefits. Nonetheless, immune-related adverse events[...] Read More
Bacterial meningitis and ventriculitis are severe central nervous system (CNS) infections characterized by high morbidity and mortality, particularly in immunocompromised patients. In clinical practice, ventriculitis is predominantly encountered as a secondary complication of invasive neurosurgical [...] Read More
We read with interest the case report by Kanat et al. entitled “Uncommon Presentation of Mycoplasma pneumoniae: Rash and Mucositis Manifestation,” recently published in Infectious Diseases and Clinical Microbiology [...] Read More
As of July 15 2026, Ebola diseases caused by Bundibugyo virus has resulted in 2124 confirmed cases including 828 deaths in Democratic Republic of the Congo. From local communities to global action, [...] Read More
